IRMD (iradimed.com) צמיחת רווח למניה השנה
IRADIMED CORPORATION (IRMD) holds a monopoly status in the MRI equipment segment, generating a stable cash flow through consumables. A comparison of annual EPS growth confirms this resilience, where the value of 8.50 represents the latest figure. The business profits from supplying unique pumps to global clinics, while strict patents and safety standards completely eliminate price competition in this niche.
פילוחי מדדים פיננסיים ומדדי שוק עבור IRADIMED CORPORATION (IRMD)
The technological dominance of IRADIMED CORPORATION (IRMD) and high margins under Roger Susi's leadership are reflected in the dynamics of the annual EPS difference in percentage terms. This indicator measures the growth rate of net income per share, revealing real capital inflows and the impact of liquidity, while extreme peaks on the chart may signal that the short-term growth potential for the stock has been exhausted.
